- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06230848
Multisensory Early Oral Administration of Human Milk in Preterm Infants (M-MILK)
January 25, 2024 updated by: Loyola University
Multisensory Early Oral Administration of Human Milk in Preterm Infants to Attenuate Early Life Toxic Stress on Epigenetic Modifications and Dysbiosis: Randomized Controlled Trial Pilot Study
More than 60,000 infants are born between 22 to 32 weeks gestation age annually in the US.
Approximately 11% of them develop comorbidities.
During NICU hospitalization, preterm infants inevitably endure early life toxic stress without adequate protective buffers.
Early life toxic stress results in adverse epigenetic modifications of glucocorticoid-related genes and dysbiosis, impairing neurodevelopment.
These adversities further exacerbate the risk of comorbidities and inappropriate brain development during sensitive periods of neuroplasticity.
Adverse epigenetic modifications and dysbiosis may set a life-long trajectory of risk for chronic health conditions.
It is a clinical and scientific priority to test an early NICU intervention to attenuate stress-related adverse epigenetic modifications and dysbiosis.
Human milk influences the structure and relative abundance of healthy gut bacteria and neurodevelopment.
Maternal nurturing, e.g., licking and grooming (in rodents), and breastfeeding and touch (in humans), promotes neurodevelopment, reduces stress, and reverses stress-related epigenetic modifications.
The multisensory early oral administration of human milk (M-MILK) intervention is designed to provide an enjoyable and nurturing experience for infants, through a safe and consistent infant-guided provision of human milk droplets, given orally as early as 22 weeks postmenstrual age.
M-MILK is implemented from day 3 of life, after every hands-on care, and during the beginning of a full gavage feeding.
We propose the M-MILK pilot randomized controlled trial (RCT): a 2-group (N = 12, 6 per group), parallel, and longitudinal design in preterm infants who are born between 22 to 28 weeks gestational age.
The aims of this pilot are to determine the feasibility and acceptability of the M-MILK intervention, recruitment, retention, and obtain data for sample size estimation.
This study will advance nursing science and practice because it will inform our R01 RCT to examine the efficacy of M-MILK to attenuate adverse effects of early life toxic stress in preterm infants.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Thao Griffith, PhD
- Phone Number: 708-216-5708
- Email: tgriffith1@luc.edu
Study Locations
-
-
Illinois
-
Maywood, Illinois, United States, 60153
- Recruiting
- Loyola University Chicago
-
Contact:
- Thao Griffith, PhD
- Phone Number: 708-216-5708
- Email: tgriffith1@luc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- born between 22 to 28 weeks gestational age and receiving mother's own milk and/or donor milk.
Exclusion Criteria:
- receiving only formula, oral cavity defects, gastrointestinal defects, chromosomal abnormalities, severe cardiac defects that require surgery, or intraventricular hemorrhage grade III or IV
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Attention Control
Infants in the attention control group will receive standard of care.
|
|
Experimental: M-MILK
Infants in the M-MILK group will receive the M-MILK intervention in addition to standard of care.
|
M-MILK is implemented as droplets, at day 3 of life, after every hands-on care, and during the beginning of a full gavage feeding.
The infant may be supportively positioned in bed, held skin-to-skin by caregiver, or held/cradled by nurse or caregiver.
The nurse draws up 1 mL of milk into the 1-mL syringe from a prepared bottle or enteral feeding syringe.
The nurse then proceeds to implement M-MILK while observing the infant's responses closely.
The nurse talks to the infant with a soft calm voice while providing gentle touch throughout the intervention.
The nurse begins M-MILK by first placing 1-2 drops of milk onto the infant's upper lip, allowing the infant to feel and smell the milk.
The nurse gently strokes the infant's lips with a pacifier/swab or infant's fingers.
M-MILK will be provided based on infants' responses and cues.
M-MILK is concluded if the infant is no longer engaged or has finished the 1 mL of milk.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of intervention
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Determine the feasibility of intervention.
M-MILK will be considered feasible if M-MILK is implemented by nurses or parents after every hands-on care and during the beginning of a full gavage feeding at least 50% of the time.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Acceptability of intervention
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percentage of parents who rate the intervention as very positive, slightly positive, or acceptable on a 5-point Likert scale.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Retention
Time Frame: 2 months corrected age
|
Retention will be described by the percentage of post-discharge follow-up surveys completed.
|
2 months corrected age
|
Variability in the Scarf Sign cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for scarf sign ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the motor development & vigor cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for motor development & vigor ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the popliteal angle cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for popliteal angle ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the alertness and orientation cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for alertness and orientation ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the irritability cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for irritability ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the quality of cry cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for quality of cry ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the percent sleep cluster of the Neurobehavioral Assessment of the Preterm Infants score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for percent sleep ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in Early Feeding Skill Assessment score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
EFS has 22 items (32-50 weeks PMA), summary scores, 5 subscales: respiratory regulation (range 5 - 15), oral-motor functioning (range 4 - 12), swallowing coordination (range 4 - 12), engagement (range 2 - 6), & physiologic stability (range 4 - 12), where higher scores indicate better oral feeding skill development.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in the Nursing Child Assessment Satellite Training-Feeding Scale score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Nursing Child Assessment Satellite Training-Feeding Scale (76 items) consists of six subscales: (a) maternal-sensitivity to cues (range 0 - 16); (b) maternal response to distress (range 0 - 11); (c) maternal social-emotional growth-fostering (range 0 - 14); (d) maternal cognitive growth fostering (range 0 -9); (e) infant clarity of cues (range 0 - 15); and (f) infant responsiveness to caregiver (range 0 - 11), where higher scores indicate better interactions and responses. .
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variability in Parent Stressor Scale: NICU score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Scores range from 26 to 130, where higher scores indicate greater parental stress..
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in Parent Discharge Readiness score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Scores range from 44 to 308, where higher scores indicate more parental readiness for discharge.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Breastmilk pumping rate
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percentage of mothers who report breastmilk pumping at discharge.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Breastfeeding rate
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percentage of mothers who report breastfeeding at discharge.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in maternal Edinburgh Postnatal Depression Scale score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Scores range from 0 to 30, where higher scores indicate greater depressive symptoms
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variability in gut microbial community structure and relative abundance of SCFA- and lactate- producing bacteria
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Alpha diversity indices will be obtained.
Differential abundance individual taxa will be obtained.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in DNA methylation of NR3C1 promoter
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percent DNAm at the NR3C1 promoters and at each CpG site will be quantified.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Variability in DNA methylation of HSD11B2 promoter
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percent DNAm at the HSD11B2 promoters and at each CpG site will be quantified.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2023
Primary Completion (Estimated)
October 23, 2024
Study Completion (Estimated)
October 23, 2024
Study Registration Dates
First Submitted
January 5, 2024
First Submitted That Met QC Criteria
January 25, 2024
First Posted (Actual)
January 30, 2024
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 25, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 217411
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Taichung Veterans General HospitalUnknown
Clinical Trials on Multisensory Early Oral Administration of Human Milk (M-MILK)
-
The University of Texas Health Science Center at...RecruitingNeonatal Abstinence SyndromeUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedPostnatal Growth Failure of Preterm Infants | Human Milk Fortification
-
University of FloridaNational Institute of Nursing Research (NINR)CompletedBreast Milk ExpressionUnited States
-
Assistance Publique - Hôpitaux de ParisESPCI ParisCompleted
-
Seattle Children's HospitalRecruitingIntestinal Obstruction | Gastroschisis | Hirschsprung Disease | Omphalocele | Gastrointestinal Complication | Midgut VolvulusUnited States
-
Mansoura University Children HospitalCompletedPreterm Infant | Feeding Disorder Neonatal | Gastrointestinal Motility DisorderEgypt
-
Mansoura University Children HospitalCompletedPreterm Infant | Neonatal SEPSIS | Neonatal Feeding DisorderEgypt
-
a2 Milk Company Ltd.Completed
-
Federal University of UberlandiaFundação de Amparo à Pesquisa do estado de Minas GeraisCompletedHealth Behavior
-
a2 Milk Company Ltd.CompletedLactose Intolerance